Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 15Phase 1/2 7Phase 1 7Phase NA 4Phase 2/3 2Phase 4 1

Status

Completed 5Terminated 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Genitourinary 1Classical hematology 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Leukemia, Myeloid, Acute 1Febrile Neutropenia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Filgrastim × Clear all
NCT02427919 2015-04-28

DeGREE

Seoul St. Mary's Hospital

Phase 2/3 Unknown
56 enrolled
Classical hematologyOther hematologic neoplasm

Leukemia, Myeloid, Acute, Febrile Neutropenia

NCT00003643 2012-03-06

Combination Chemotherapy in Treating Men With Germ Cell Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
498 enrolled
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡